The stock of Mettrum Health Corp (CVE:MT) hit a new 52-week high and has $7.95 target or 6.00% above today’s $7.50 share price. The 5 months bullish chart indicates low risk for the $366.80M company. The 1-year high was reported on Dec, 1 by Barchart.com. If the $7.95 price target is reached, the company will be worth $22.01M more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock. About 3.90 million shares traded hands or 248.21% up from the average. Mettrum Health Corp (CVE:MT) has risen 6.00% since November 1, 2016 and is uptrending. It has outperformed by 0.07% the S&P500.
More recent Mettrum Health Corp (CVE:MT) news were published by: Midasletter.com which released: “Mettrum Health Corp (CVE:MT)’s takeover by Canopy Growth Corp (TSE:CGC): Who’s …” on December 01, 2016. Also Investingnews.com published the news titled: “Mettrum Health” on June 06, 2016. Reuters.com‘s news article titled: “BRIEF-Mettrum Health Corp says all licenses at Bowmanville facilities rene…” with publication date: November 02, 2016 was also an interesting one.
Mettrum Health Corp. is a producer of medical cannabis. The company has a market cap of $366.80 million. The Firm is also a licensed producer and distributer of industrial cannabis (hemp) products, including Mettrum’s functional food line, Mettrum Originals. It currently has negative earnings. It has a production capacity of over 12,000 kilograms of medical cannabis per year.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.